This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Mar 15;167(6):819-23.

doi: 10.1164/rccm.200109-012CC.

Aminoglycoside prescribing and surveillance in cystic fibrosis

Kelvin H-V Tan¹, Michael Mulheran, Alan J Knox, Alan R Smyth

Affiliations

PMID: 12623858
DOI: 10.1164/rccm.200109-012CC

Review

Aminoglycoside prescribing and surveillance in cystic fibrosis

Kelvin H-V Tan et al. Am J Respir Crit Care Med. 2003.

. 2003 Mar 15;167(6):819-23.

doi: 10.1164/rccm.200109-012CC.

Authors

Kelvin H-V Tan¹, Michael Mulheran, Alan J Knox, Alan R Smyth

Affiliation

¹ Division of Respiratory Medicine, Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. Kelvin.Tan@nottingham.ac.uk

PMID: 12623858
DOI: 10.1164/rccm.200109-012CC

No abstract available

PubMed Disclaimer

Similar articles

[Warning about overconsumption of psychotropic drugs in adolescents].
Hansen BB. Hansen BB. Soins Pediatr Pueric. 2005 Apr;(223):7. Soins Pediatr Pueric. 2005. PMID: 15869026 French. No abstract available.
Redefining appropriate use of antibiotics.
Gums JG. Gums JG. Am Fam Physician. 2004 Jan 1;69(1):35, 39-40. Am Fam Physician. 2004. PMID: 14727818 Review. No abstract available.
Evaluation of drug use in Jordan using WHO prescribing indicators.
Otoom S, Batieha A, Hadidi H, Hasan M, Al-Saudi K. Otoom S, et al. East Mediterr Health J. 2002 Jul-Sep;8(4-5):537-43. East Mediterr Health J. 2002. PMID: 15603035
A prescription for disaster.
Gillan J. Gillan J. Nurs Times. 1999 Nov 3-9;95(44):22. Nurs Times. 1999. PMID: 10983071 No abstract available.
Aminoglycosides: assessing the potential for nephrotoxicity.
Wilson SE. Wilson SE. Surg Gynecol Obstet. 1990;171 Suppl:24-30. Surg Gynecol Obstet. 1990. PMID: 2244292 Review.

See all similar articles

Cited by

Mechanisms and Delivery of tRNA Therapeutics.
Ward C, Beharry A, Tennakoon R, Rozik P, Wilhelm SDP, Heinemann IU, O'Donoghue P. Ward C, et al. Chem Rev. 2024 Jun 26;124(12):7976-8008. doi: 10.1021/acs.chemrev.4c00142. Epub 2024 May 27. Chem Rev. 2024. PMID: 38801719 Review.
Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study.
Jouret N, Van der Poel N, Verhulst S, Lammers M, Van Rompaey V, Jacquemin L, Van Hoorenbeeck K. Jouret N, et al. Heliyon. 2024 Jan 26;10(3):e25190. doi: 10.1016/j.heliyon.2024.e25190. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38333844 Free PMC article.
Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.
Garinis AC, Poling GL, Rubenstein RC, Konrad-Martin D, Hullar TE, Baguley DM, Burrows HL, Chisholm JA, Custer A, Hawe LD, Hunter LL, Marras TK, Ortiz CE, Petersen L, Steyger PS, Winthrop K, Zettner EM, Clark K, Hungerford M, Vachhani JJ, Brewer CC. Garinis AC, et al. Am J Audiol. 2021 Oct 11;30(3S):800-809. doi: 10.1044/2021_AJA-21-00031. Epub 2021 Sep 22. Am J Audiol. 2021. PMID: 34549989 Free PMC article.
Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis.
Dong M, Rodriguez AV, Blankenship CA, McPhail G, Vinks AA, Hunter LL. Dong M, et al. J Antimicrob Chemother. 2021 Oct 11;76(11):2923-2931. doi: 10.1093/jac/dkab288. J Antimicrob Chemother. 2021. PMID: 34379758 Free PMC article.
N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.
Ejigu DA, Abay SM. Ejigu DA, et al. Tuberc Res Treat. 2020 Apr 30;2020:5907839. doi: 10.1155/2020/5907839. eCollection 2020. Tuberc Res Treat. 2020. PMID: 32411461 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information